Antibiotic therapy for anaerobic infections.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D001442:Bacteroides Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D008802:Mezlocillin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008795:Metronidazole; D002981:Clindamycin; D002701:Chloramphenicol; D013982:Ticarcillin; D002228:Carbenicillin; D008802:Mezlocillin; D010400:Penicillin G